Evidence mapPaperPMID 42136439Full record

ArticleWorld psychiatry : official journal of the World Psychiatric Association (WPA)2026

Child and adolescent psychiatry: challenges, solutions, opportunities, and future directions.

Samuele Cortese, Celso Arango, Claudia Aymerich, Ana Catalan, Mohamed Chetouani, David Cohen, David Coghill, Alessandra Gabellone, Raquel Iniesta, Anoop Kadan and 22 more

Abstract read
In one paragraph

Article in World psychiatry : official journal of the World Psychiatric Association (WPA), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Samuele CorteseDevelopmental EPI (Evidence synthesis, Prediction, Implementation) Lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.
Celso ArangoHospital Universitario La Paz, School of Medicine, Universidad Autónoma de Madrid, CiBERSAM, Madrid, Spain.
Claudia AymerichDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Ana CatalanBiobizkaia Health Research Institute, University of the Basque Country, Bilbao, Spain.
Mohamed ChetouaniInstitute for Intelligent Systems and Robotics, Sorbonne University, UMR 7222, Inserm U1150, Paris, France.
David CohenDepartment of Child and Adolescent Psychiatry, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
David CoghillDepartment of Paediatrics, University of Melbourne, and Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Alessandra GabelloneChildhood and Adolescence Neuropsychiatry Complex Operative Unit, Department of Neuroscience, Policlinico "Riuniti", Foggia, Italy.
Raquel IniestaDepartment of Biostatistics & Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Anoop KadanDevelopmental EPI (Evidence synthesis, Prediction, Implementation) Lab, Centre for Innovation in Mental Health, School of Psychology, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, UK.
Hala KerbageDepartment of Child and Adolescent Psychiatry, Saint Eloi Hospital, CHU Montpellier, Montpellier, France.
Lars Vedel KessingCopenhagen Affective Disorder Research Centre, Psychiatric Centre Copenhagen, Copenhagen, Denmark.
Lucia MargariDepartment of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", Bari, Italy.
Emilia MateraDepartment of Precision and Regenerative Medicine and Ionian Area, University of Bari "Aldo Moro", Bari, Italy.
Lucia MarzulliChildhood and Adolescence Neuropsychiatry Complex Operative Unit, Department of Mental Health, Taranto, Italy.
Signe MezinskaInstitute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia.
Melissa MulraneyDepartment of Paediatrics, University of Melbourne, and Murdoch Children's Research Institute, Melbourne, VIC, Australia.
Peter NagyBethesda Children's Hospital, Budapest, Hungary.
Dominic OliverEarly Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, King's College London, London, UK.
Anne Katrine PagsbergCopenhagen Affective Disorder Research Centre, Psychiatric Centre Copenhagen, Copenhagen, Denmark.
Maria Giuseppina PetruzzelliDepartment of Translational Biomedicine and Neurosciences, University of Bari "A. Moro", Bari, Italy.
Veit RoessnerDepartment of Child and Adolescent Psychiatry and Psychotherapy, Faculty of Medicine, Dresden University of Technology, Dresden, Germany.
Gonzalo Salazar de PabloDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Paramala SantoshDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Dejan StevanovicClinic for Neurology and Psychiatry for Children and Youth, Belgrade, Serbia.
Gisela SugranyesFundació Clínic de Recerca Biomèdica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain.
Eduard VietaFundació Clínic de Recerca Biomèdica, Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain.
Christoph U CorrellDepartment of Psychiatry and Molecular Medicine, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Gil ZalsmanGeha Mental Health Center, Petah Tikva, Israel.
Diane Purper-OuakilDepartment of Child and Adolescent Psychiatry, Saint Eloi Hospital, CHU Montpellier, Montpellier, France.
Carmen MorenoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario "G. Marañón", IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain.
Paolo Fusar-PoliEarly Psychosis: Interventions and Clinical-detection (EPIC) Lab, Department of Psychosis Studies, King's College London, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is estimated that, globally, the mean point prevalence of diagnosable mental disorders in children and adolescents is higher than 11%, and around half of cases of major mental disorders have their onset before the age of 18. Mental disorders with onset in childhood or adolescence have an enormous impact on the developing brain, body and personal identity, as well as on the short- and long-term social, educational and functional capacity of individuals. Child and adolescent psychiatry - as a discipline, profession, academic field, and network of clinical services - is still relatively young, with its formal evolution beginning in the 20th century. Therefore, it is not surprising that there are currently many challenges, but also opportunities and expected future developments, in this area. In this paper, we identify and address the core challenges, possible solutions, opportunities, and future directions of child and adolescent psychiatry. In the first part of the paper, challenges and possible solutions are discussed regarding diagnostic issues, stigma, access to care, shortage of mental health professionals, evidence-based treatments, treatment adherence, parental participation/engagement, integration with schools, digital influences and cyberbullying, and war/forced displacement. In the second part, opportunities and developments are addressed that relate to early identification and intervention, resilience, interdisciplinary collaborations, integration with primary care, community-based approaches, use of digital technologies, precision child and adolescent psychiatry, artificial intelligence and related ethical issues, and cultural diversity and competences. Despite the significance and impact of mental disorders in children and adolescents, clinical delivery and research on these conditions remain underfunded and underprioritized, even in high-income countries, with clinical services and prevention/early intervention research receiving minimal investment. Addressing mental health in children and young people requires multi-level strategies beyond individual treatment, including tackling structural and socioeconomic barriers and creating opportunities for strengthening resilience and well-being. A well-trained workforce, adequate policies, and increased public awareness are crucial. Overall, the current gaps demand urgent action and global funding rebalancing to more adequately meet the critical needs of children and young people challenged by mental illness.

Indexed as

adolescentschild and adolescent psychiatryChildrendiagnostic issuesdigital technologiesearly interventionevidence‐based treatmentsinterdisciplinary collaborationsmental healthresilience

Identifiers

PMID42136439
PMCPMC13176884

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.